86 results
424B3
PRTG
Portage Biotech Inc
7 Nov 23
Prospectus supplement
4:50pm
corporate governance practices rather than those of Nasdaq. For example, British Virgin Islands law does not require that a majority of our board … ability to rely upon exemptions from certain corporate governance requirements under the listing rules of Nasdaq. As a U.S. listed public company
F-1
PRTG
Portage Biotech Inc
31 Oct 23
Registration statement (foreign)
4:05pm
.
In accordance with Nasdaq Listing Rule 5615(a)(3), we have also elected to follow home country corporate governance practices rather than those of Nasdaq … governance requirements under the listing rules of Nasdaq. As a U.S. listed public company that is not a foreign private issuer, we would expect to incur
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
.
Attract leading collaborators and licensors: Each of our subsidiaries has its own capitalization and governance, enabling us to keep licensors
6-K
EX-2.1
72jfvgs3 ryi003qks
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-99.2
zqh0q1i 6earyxoq8o
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
jof2ys2rl6yc2c0 y0
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
rqkixpi4irr00upvnf
30 Aug 21
Current report (foreign)
5:21pm
SUPPL
8jbj0u 66ggfxceo49
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
hv44hnq1q be4qec5
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
989i3
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.2
vjux77sgpbi7
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
6-K
EX-99.1
1sn4mybyxlf0
25 Feb 21
Current report (foreign)
8:11am
F-3
82iyc7
24 Feb 21
Shelf registration (foreign)
5:22pm